BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 19464323)

  • 1. The antihyperalgesic activity of a selective P2X7 receptor antagonist, A-839977, is lost in IL-1alphabeta knockout mice.
    Honore P; Donnelly-Roberts D; Namovic M; Zhong C; Wade C; Chandran P; Zhu C; Carroll W; Perez-Medrano A; Iwakura Y; Jarvis MF
    Behav Brain Res; 2009 Dec; 204(1):77-81. PubMed ID: 19464323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A-740003 [N-(1-{[(cyanoimino)(5-quinolinylamino) methyl]amino}-2,2-dimethylpropyl)-2-(3,4-dimethoxyphenyl)acetamide], a novel and selective P2X7 receptor antagonist, dose-dependently reduces neuropathic pain in the rat.
    Honore P; Donnelly-Roberts D; Namovic MT; Hsieh G; Zhu CZ; Mikusa JP; Hernandez G; Zhong C; Gauvin DM; Chandran P; Harris R; Medrano AP; Carroll W; Marsh K; Sullivan JP; Faltynek CR; Jarvis MF
    J Pharmacol Exp Ther; 2006 Dec; 319(3):1376-85. PubMed ID: 16982702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. P2X7-related modulation of pathological nociception in rats.
    McGaraughty S; Chu KL; Namovic MT; Donnelly-Roberts DL; Harris RR; Zhang XF; Shieh CC; Wismer CT; Zhu CZ; Gauvin DM; Fabiyi AC; Honore P; Gregg RJ; Kort ME; Nelson DW; Carroll WA; Marsh K; Faltynek CR; Jarvis MF
    Neuroscience; 2007 Jun; 146(4):1817-28. PubMed ID: 17478048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [3H]A-804598 ([3H]2-cyano-1-[(1S)-1-phenylethyl]-3-quinolin-5-ylguanidine) is a novel, potent, and selective antagonist radioligand for P2X7 receptors.
    Donnelly-Roberts DL; Namovic MT; Surber B; Vaidyanathan SX; Perez-Medrano A; Wang Y; Carroll WA; Jarvis MF
    Neuropharmacology; 2009 Jan; 56(1):223-9. PubMed ID: 18602931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. P2X7-dependent release of interleukin-1beta and nociception in the spinal cord following lipopolysaccharide.
    Clark AK; Staniland AA; Marchand F; Kaan TK; McMahon SB; Malcangio M
    J Neurosci; 2010 Jan; 30(2):573-82. PubMed ID: 20071520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A role for cannabinoid receptors, but not endogenous opioids, in the antinociceptive activity of the CB2-selective agonist, GW405833.
    Whiteside GT; Gottshall SL; Boulet JM; Chaffer SM; Harrison JE; Pearson MS; Turchin PI; Mark L; Garrison AE; Valenzano KJ
    Eur J Pharmacol; 2005 Dec; 528(1-3):65-72. PubMed ID: 16316650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peripheral P2X7 receptor-induced mechanical hyperalgesia is mediated by bradykinin.
    Teixeira JM; de Oliveira-Fusaro MC; Parada CA; Tambeli CH
    Neuroscience; 2014 Sep; 277():163-73. PubMed ID: 24997266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of A-317491, a novel and selective P2X3/P2X2/3 receptor antagonist, on neuropathic, inflammatory and chemogenic nociception following intrathecal and intraplantar administration.
    McGaraughty S; Wismer CT; Zhu CZ; Mikusa J; Honore P; Chu KL; Lee CH; Faltynek CR; Jarvis MF
    Br J Pharmacol; 2003 Dec; 140(8):1381-8. PubMed ID: 14623769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. P2X7 receptor differentially couples to distinct release pathways for IL-1beta in mouse macrophage.
    Pelegrin P; Barroso-Gutierrez C; Surprenant A
    J Immunol; 2008 Jun; 180(11):7147-57. PubMed ID: 18490713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of chemokine expression in rat inflamed paws by systemic use of the antihyperalgesic oxidized ATP.
    Fulgenzi A; Dell'Antonio G; Foglieni C; Dal Cin E; Ticozzi P; Franzone JS; Ferrero ME
    BMC Immunol; 2005 Jul; 6():18. PubMed ID: 16042776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mammalian P2X7 receptor pharmacology: comparison of recombinant mouse, rat and human P2X7 receptors.
    Donnelly-Roberts DL; Namovic MT; Han P; Jarvis MF
    Br J Pharmacol; 2009 Aug; 157(7):1203-14. PubMed ID: 19558545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological characterization of a novel centrally permeable P2X7 receptor antagonist: JNJ-47965567.
    Bhattacharya A; Wang Q; Ao H; Shoblock JR; Lord B; Aluisio L; Fraser I; Nepomuceno D; Neff RA; Welty N; Lovenberg TW; Bonaventure P; Wickenden AD; Letavic MA
    Br J Pharmacol; 2013 Oct; 170(3):624-40. PubMed ID: 23889535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of temporomandibular joint P2X3 and P2X2/3 receptors in carrageenan-induced inflammatory hyperalgesia in rats.
    Teixeira JM; Oliveira MC; Nociti FH; Clemente-Napimoga JT; Pelegrini-da-Silva A; Parada CA; Tambeli CH
    Eur J Pharmacol; 2010 Oct; 645(1-3):79-85. PubMed ID: 20558155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. P2X7 receptor mediates activation of microglial cells in prostate of chemically irritated rats.
    Zhang H; Liu L; Yang Z; Pan J; Chen Z; Fang Q; Li W; Li L; Lu G; Zhou Z
    Int Braz J Urol; 2013; 39(2):276-85. PubMed ID: 23683674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of the damage-associated molecular pattern receptor P2X7 induces interleukin-1β release from canine monocytes.
    Jalilian I; Peranec M; Curtis BL; Seavers A; Spildrejorde M; Sluyter V; Sluyter R
    Vet Immunol Immunopathol; 2012 Sep; 149(1-2):86-91. PubMed ID: 22652409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-1alphabeta gene-deficient mice show reduced nociceptive sensitivity in models of inflammatory and neuropathic pain but not post-operative pain.
    Honore P; Wade CL; Zhong C; Harris RR; Wu C; Ghayur T; Iwakura Y; Decker MW; Faltynek C; Sullivan J; Jarvis MF
    Behav Brain Res; 2006 Feb; 167(2):355-64. PubMed ID: 16256210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuropsychopharmacology of JNJ-55308942: evaluation of a clinical candidate targeting P2X7 ion channels in animal models of neuroinflammation and anhedonia.
    Bhattacharya A; Lord B; Grigoleit JS; He Y; Fraser I; Campbell SN; Taylor N; Aluisio L; O'Connor JC; Papp M; Chrovian C; Carruthers N; Lovenberg TW; Letavic MA
    Neuropsychopharmacology; 2018 Dec; 43(13):2586-2596. PubMed ID: 30026598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Silica nanoparticles activate purinergic signaling via P2X7 receptor in dendritic cells, leading to production of pro-inflammatory cytokines.
    Nakanishi K; Tsukimoto M; Tanuma S; Takeda K; Kojima S
    Toxicol In Vitro; 2016 Sep; 35():202-11. PubMed ID: 27311643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peripheral mechanisms underlying the essential role of P2X7 receptors in the development of inflammatory hyperalgesia.
    Teixeira JM; Oliveira MC; Parada CA; Tambeli CH
    Eur J Pharmacol; 2010 Oct; 644(1-3):55-60. PubMed ID: 20621090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electroacupuncture Relieves Nerve Injury-Induced Pain Hypersensitivity via the Inhibition of Spinal P2X7 Receptor-Positive Microglia.
    Xu J; Chen XM; Zheng BJ; Wang XR
    Anesth Analg; 2016 Mar; 122(3):882-892. PubMed ID: 26599792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.